Long-term results of high-dose-rate brachytherapy in the primary treatment of medically inoperable stage I–II endometrial carcinoma

This publication has 25 references indexed in Scilit:

• A prospective population-based management program including primary surgery and postoperative risk assessment by means of DNA ploidy and histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with FIGO stage I-II endometrial cancer
  International Journal of Gynecological Cancer, 2004
• High-Dose-Rate Brachytherapy for Medically Inoperable Stage I Endometrial Cancer
  Gynecologic Oncology, 1998
• Radiation Therapy as Exclusive Treatment for Medically Inoperable Patients with Stage I and II Endometrioid Carcinoma of the Endometrium
  Gynecologic Oncology, 1996
• High-Dose-Rate Brachytherapy as the Primary Treatment of Medically Inoperable Stage I–II Endometrial Carcinoma
  Gynecologic Oncology, 1995
• High dose rate versus low dose rate brachytherapy for gynecological cancer
  Seminars in Radiation Oncology, 1993
• Prognostic factors and sites of failure in figo Stage I, Grade 3 endometrial carcinoma
  Gynecologic Oncology, 1987
• Physical characteristics of the Selectron high dose rate intracavitary afterloader
  British Journal of Radiology, 1985
• Stage I grade III endometrial carcinoma: Evaluation of treatment and recommendations for management
  Gynecologic Oncology, 1981
• Irradiation of endometrial cancer in patients with medical contraindication to surgery or with unresectable lesions
  American Journal of Roentgenology, 1976
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958